BRIGHT MINDS BIOSCIENCES INC. Equity
BRIGHT MINDS BIOSCIENCES INC. (DRUG) had Equity of CAD 5.54 million as of 2024-09-30, per its 20-F filed 2024-12-31.
Financial Statements › Notes
ifrs-full:Equity · last filed 2024-12-31
- 2024-09-30: Equity 5.54M CAD.
- 2023-09-30: Equity 6.60M CAD.
- 2022-09-30: Equity 10.54M CAD.
- 2021-09-30: Equity 19.40M CAD.
| Period end | Equity |
|---|---|
| 2024-09-30 | 5.54M CAD 20-F · filed 2024-12-31 |
| 2023-09-30 | 6.60M CAD 20-F · filed 2024-12-31 |
| 2022-09-30 | 10.54M CAD 20-F · filed 2024-12-31 |
| 2021-09-30 | 19.40M CAD 20-F · filed 2024-12-31 |
| 2020-09-30 | 729.29K CAD 20-F · filed 2023-12-29 |
| 2019-09-30 | 45.28K CAD 20-F · filed 2022-12-29 |
| 2019-05-31 | 0.00 CAD 20-F/A · filed 2022-01-18 |